Definitive Healthcare Corp (DH)

$9.16

-0.09

(-0.97%)

Market is closed - opens 8 PM, 26 Feb 2024

Insights on Definitive Healthcare Corp

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 59.20M → 65.32M (in $), with an average increase of 4.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -8.56M → -171.52M (in $), with an average decrease of 1902.4% per quarter

  • Vs VEEV

    In the last 1 year, Veeva Systems Inc. has given 34.2% return, outperforming this stock by 58.0%

Performance

  • $9.07
    $9.32
    $9.16
    downward going graph

    0.98%

    Downside

    Day's Volatility :2.68%

    Upside

    1.72%

    downward going graph
  • $5.53
    $12.59
    $9.16
    downward going graph

    39.63%

    Downside

    52 Weeks Volatility :56.08%

    Upside

    27.24%

    downward going graph

Returns

PeriodDefinitive Healthcare CorpSector (Health Care)Index (Russel 2000)
3 Months
14.64%
12.8%
0.0%
6 Months
-2.35%
10.8%
0.0%
1 Year
-18.72%
15.1%
-6.4%
3 Years
-78.84%
30.2%
-19.6%

Highlights

Market Capitalization
1.1B
Book Value
$7.42
Earnings Per Share (EPS)
-1.61
Wall Street Target Price
10.15
Profit Margin
-74.08%
Operating Margin TTM
-6.85%
Return On Assets TTM
-1.0%
Return On Equity TTM
-20.17%
Revenue TTM
246.1M
Revenue Per Share TTM
2.24
Quarterly Revenue Growth YOY
13.8%
Gross Profit TTM
196.8M
EBITDA
20.0M
Diluted Eps TTM
-1.61
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.31
EPS Estimate Next Year
0.32
EPS Estimate Current Quarter
0.06
EPS Estimate Next Quarter
0.04

Analyst Recommendation

Buy
    61%Buy
    38%Hold
    0
    0%Sell
Based on 21 Wall street analysts offering stock ratings for Definitive Healthcare Corp(by analysts ranked 0 to 5 stars)
Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
13
Hold
8
8
9
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 10.81%

Current $9.16
Target $10.15

Company Financials

FY20Y/Y Change
Revenue
118.3M
-
Net Income
-87.6M
-
Net Profit Margin
-74.08%
-
FY21Y/Y Change
Revenue
166.2M
↑ 40.43%
Net Income
-61.3M
↓ 30.11%
Net Profit Margin
-36.87%
↑ 37.21%
FY22Y/Y Change
Revenue
222.7M
↑ 34.0%
Net Income
-22.3M
↓ 63.67%
Net Profit Margin
-10.0%
↑ 26.87%
FY23Y/Y Change
Revenue
246.1M
↑ 10.52%
Net Income
-181.1M
↑ 713.77%
Net Profit Margin
-73.6%
↓ 63.6%
Q2 FY22Q/Q Change
Revenue
54.5M
↑ 8.83%
Net Income
-9.6M
↓ 26.64%
Net Profit Margin
-17.56%
↑ 8.49%
Q3 FY22Q/Q Change
Revenue
57.4M
↑ 5.2%
Net Income
-6.4M
↓ 33.67%
Net Profit Margin
-11.07%
↑ 6.49%
Q4 FY22Q/Q Change
Revenue
60.6M
↑ 5.61%
Net Income
6.7M
↓ 206.0%
Net Profit Margin
11.11%
↑ 22.18%
Q1 FY23Q/Q Change
Revenue
59.2M
↓ 2.31%
Net Income
-15.6M
↓ 331.63%
Net Profit Margin
-26.35%
↓ 37.46%
Q2 FY23Q/Q Change
Revenue
61.0M
↑ 2.97%
Net Income
-8.6M
↓ 45.09%
Net Profit Margin
-14.05%
↑ 12.3%
Q3 FY23Q/Q Change
Revenue
65.3M
↑ 7.17%
Net Income
-171.5M
↑ 1902.4%
Net Profit Margin
-262.57%
↓ 248.52%
FY19Y/Y Change
Total Assets
1.7B
-
Total Liabilities
504.9M
-
FY20Y/Y Change
Total Assets
1.7B
↑ 1.41%
Total Liabilities
549.8M
↑ 8.89%
FY21Y/Y Change
Total Assets
2.1B
↑ 21.24%
Total Liabilities
612.7M
↑ 11.45%
FY22Y/Y Change
Total Assets
2.1B
↑ 0.24%
Total Liabilities
633.8M
↑ 3.43%
Q2 FY22Q/Q Change
Total Assets
2.1B
↓ 0.88%
Total Liabilities
634.2M
↓ 1.6%
Q3 FY22Q/Q Change
Total Assets
2.1B
↓ 0.15%
Total Liabilities
642.3M
↑ 1.28%
Q4 FY22Q/Q Change
Total Assets
2.1B
↑ 0.06%
Total Liabilities
633.8M
↓ 1.32%
Q1 FY23Q/Q Change
Total Assets
2.1B
↓ 0.27%
Total Liabilities
645.8M
↑ 1.9%
Q2 FY23Q/Q Change
Total Assets
2.1B
↓ 0.49%
Total Liabilities
649.4M
↑ 0.56%
Q3 FY23Q/Q Change
Total Assets
1.8B
↓ 13.56%
Total Liabilities
616.1M
↓ 5.13%
FY19Y/Y Change
Operating Cash Flow
21.6M
-
Investing Cash Flow
-1.1B
-
Financing Cash Flow
1.1B
-
FY20Y/Y Change
Operating Cash Flow
23.2M
↑ 7.52%
Investing Cash Flow
-23.9M
↓ 97.91%
Financing Cash Flow
16.7M
↓ 98.52%
FY21Y/Y Change
Operating Cash Flow
25.2M
↑ 8.59%
Investing Cash Flow
-46.7M
↑ 95.84%
Financing Cash Flow
384.4M
↑ 2207.85%
FY22Y/Y Change
Operating Cash Flow
35.6M
↑ 41.12%
Investing Cash Flow
-248.9M
↑ 432.63%
Financing Cash Flow
-26.7M
↓ 106.95%
Q2 FY22Q/Q Change
Operating Cash Flow
15.5M
↑ 13.56%
Investing Cash Flow
-10.2M
↓ 93.9%
Financing Cash Flow
-6.7M
↑ 54.2%
Q3 FY22Q/Q Change
Operating Cash Flow
10.7M
↓ 30.98%
Investing Cash Flow
-4.0M
↓ 60.87%
Financing Cash Flow
-6.1M
↓ 9.38%
Q4 FY22Q/Q Change
Operating Cash Flow
-4.2M
↓ 139.49%
Investing Cash Flow
-67.9M
↑ 1603.97%
Financing Cash Flow
-9.5M
↑ 54.65%
Q1 FY23Q/Q Change
Operating Cash Flow
15.0M
↓ 454.43%
Investing Cash Flow
-33.5M
↓ 50.7%
Financing Cash Flow
-3.5M
↓ 62.73%
Q2 FY23Q/Q Change
Operating Cash Flow
12.0M
↓ 19.52%
Investing Cash Flow
-33.5M
↑ 0.0%
Financing Cash Flow
-5.6M
↑ 59.74%

Technicals Summary

Sell

Neutral

Buy

Definitive Healthcare Corp is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Definitive Healthcare Corp
Definitive Healthcare Corp
-0.54%
-2.35%
-18.72%
-78.84%
-78.84%
10x Genomics Inc
10x Genomics Inc
6.08%
-6.08%
-5.76%
-74.02%
-14.73%
Veeva Systems Inc.
Veeva Systems Inc.
6.46%
17.19%
33.72%
-21.11%
85.04%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
22.23%
29.86%
17.14%
47.25%
47.25%
Healthequity Inc
Healthequity Inc
6.35%
20.66%
26.12%
-1.63%
0.76%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Definitive Healthcare Corp
Definitive Healthcare Corp
NA
NA
NA
0.31
-0.2
-0.01
NA
7.42
10x Genomics Inc
10x Genomics Inc
NA
NA
NA
-1.61
-0.33
-0.12
NA
6.22
Veeva Systems Inc.
Veeva Systems Inc.
63.66
63.66
1.66
4.76
0.15
0.05
NA
27.21
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
29.2
29.2
20.43
4.29
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
243.59
243.59
1.18
2.15
0.02
0.02
NA
23.17
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Definitive Healthcare Corp
Definitive Healthcare Corp
Buy
$1.1B
-78.84%
NA
-74.08%
10x Genomics Inc
10x Genomics Inc
Buy
$5.4B
-14.73%
NA
-41.23%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$35.8B
85.04%
63.66
24.68%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$40.4B
47.25%
29.2
8.02%
Healthequity Inc
Healthequity Inc
Buy
$7.1B
0.76%
243.59
3.0%

Institutional Holdings

  • Advent International Corp

    53.72%
  • Conestoga Capital Advisors, LLC

    4.75%
  • JPMorgan Chase & Co

    4.36%
  • Vanguard Group Inc

    3.72%
  • Brown Advisory Holdings Inc

    3.41%
  • BlackRock Inc

    3.23%

Corporate Announcements

  • Definitive Healthcare Corp Earnings

    Definitive Healthcare Corp’s price-to-earnings ratio stands at None

    Read More

Company Information

definitive healthcare is the leading provider of data and intelligence on hospitals, physicians and other healthcare providers. their product suite provides the most comprehensive and highest quality data available anywhere on over 8,100 hospitals and idns, 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 acos and hies, 197,000 physician groups, 1.3 million physicians, and 750 canadian hospitals. the company’s data provides clients with the analytics and insight needed to effectively segment and research the healthcare provider market. definitive healthcare is backed by spectrum equity. for more information or to trial the service, visit www.definitivehc.com.

Organization
Definitive Healthcare Corp
Employees
946
CEO
Mr. Jason Ronald Krantz
Industry
Technology

FAQs